Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-Ab™
Target-Humanized Mouse Models (HUGO-GT™)
Target-Humanized Mouse Models (CDS)
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Custom Model Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Preclinical Solutions
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic
Obesity
MASH & MASLD
Cardiovascular
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Retinal-related diseases
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Systemic Lupus Erythematosus
Drug Classification
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
iCyagen
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Company Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeBlogs & InsightsSH-SY5Y Cells: Culture Conditions, Applications, and Gene Editing
Neuroscience

SH-SY5Y Cells: Culture Conditions, Applications, and Gene Editing

Cyagen Technical Content Team | Updated on November 10, 2026
Explore SH-SY5Y Cells for Neuroscience Research
Find SH-SY5Y cells for neurodegeneration, neurotoxicity, and related cellular studies.
Explore SH-SY5Y Cells for Neuroscience Research
Contents
01. SH-SY5Y Cells: Culture Conditions, Applications, and Gene Editing 02. What Are SH-SY5Y Cells? 03. What Are SH-SY5Y Cells Used For? 04. How to Culture SH-SY5Y Cells 05. How to Edit the SH-SY5Y Cell Line (KO / KI / Point Mutation) 06. Custom Cell Line Gene Editing Services by Cyagen 07. Reference

The SH-SY5Y cell line is one of the most widely used cell models for studying neurodegenerative diseases. In this post, we provide details on how to utilize the SH-SY5Y cell line for research purposes, including protocols for successful gene editing and cell culture.

What Are SH-SY5Y Cells?

Cell Line Name: SH-SY5Y (Human Neuroblastoma Cells)

Catalog Number: CYTC00073

Growth Characteristics: Grows in clusters or aggregates, with a small portion remaining in suspension

Culture Conditions: EMEM:F12 (1:1) + 10% FBS + glutamine + NEAA + sodium pyruvate

Culture Environment: 95% air + 5% CO₂; 37 °C

The SH-SY5Y cell line is a thrice-subcloned derivative of the neuroblastoma cell line SK-N-SH (ATCC HTB-11) (SK-N-SH → SH-SY → SH-SY5 → SH-SY5Y). SK-N-SH was first established in 1970 from a metastatic bone tumor in a 4-year-old patient [1].

Unlike mature post-mitotic neurons, SH-SY5Y cells can proliferate and be expanded through repeated passages. As undifferentiated cells, they display neuroblast-like morphology and express selected neuronal markers. Under defined differentiation conditions, they can acquire additional neuron-like characteristics, although their tumor-derived origin means they do not fully reproduce the biology of mature human neurons.

Genetically edited SH-SY5Y cell lines are also useful tools in pharmacology and neuroscience research.

What Are SH-SY5Y Cells Used For?

SH-SY5Y cells are widely used as an in vitro model in neurodegenerative disease and neurotoxicity research. Their ability to acquire neuron-like characteristics under defined conditions allows researchers to select a differentiation protocol suited to the question they want to study.

Neurodegenerative Disease Research

Alzheimer's Disease: Used to study the toxic effects of β-amyloid (Aβ) and Tau protein accumulation on neurons.

Parkinson's Disease: Used to investigate selected mechanisms relevant to Parkinson's disease, including α-synuclein-related pathology, oxidative stress, and dopaminergic-associated cellular responses, depending on the differentiation state and experimental design.

Neurotoxicity Research

SH-SY5Y cells are used to assess the toxic effects of chemicals, drugs, and environmental toxins in vitro. This model has also been used to study how excess cholesterol contributes to cell injury. High cholesterol levels in the brain have been linked to Aβ accumulation and oxidative stress. In one study, researchers used cholesterol-loaded SH-SY5Y cells to examine whether inflammasome activation contributes to pyroptosis, a form of inflammatory cell death [2].

Figure 1. Study examining the role of inflammasome activation in pyroptosis in SH-SY5Y cells under high cholesterol load [2].
Figure 1. Study examining the role of inflammasome activation in pyroptosis in SH-SY5Y cells under high cholesterol load [2].

Neuronal Differentiation

SH-SY5Y cells can acquire neuron-like morphology and express selected neuronal markers following treatment with differentiation agents such as retinoic acid (RA). Some protocols use RA in combination with brain-derived neurotrophic factor (BDNF). The resulting phenotype depends on the differentiation protocol and should be characterized using appropriate morphological, molecular, and functional readouts.

Gene Function

Study the role of specific genes in neuronal function and disease through gene knockout, overexpression, or RNA interference.

Signal Transduction

Investigate neuronal signal transduction pathways, such as calcium signaling, the MAPK/ERK pathway, and the PI3K/Akt pathway.

How to Culture SH-SY5Y Cells

In practice, SH-SY5Y cells are relatively sensitive and proliferate slowly, making it challenging to prepare single clones. To ensure the stability of SH-SY5Y cells and the reliability of experimental results, it is essential to master culture techniques suited to the unique needs of this cell line.

Cell Culture Procedure of SH-SY5Y

1. Cell Thawing

  • Add 6 mL of complete culture medium to a centrifuge tube to begin thawing.
  • Thaw the cells in a water bath until only a small ice pellet remains, then stop the water bath.
  • Transfer the cell suspension to the centrifuge tube and centrifuge.
  • Resuspend the cells and seed them into an appropriately sized culture dish.
  • After 24 h, check for cell adhesion and change the medium once.

2. Cell Passaging

  • Collect the culture medium containing floating cells and recover them by centrifugation when appropriate.
  • Rinse the adherent cells once with room-temperature PBS.
  • Detach the adherent cells using a validated trypsinization procedure.
  • Gently resuspend the detached cells and combine them with any recovered floating cells.
  • Resuspend the combined cells in fresh medium and reseed at the desired split ratio.

3. Cell Cryopreservation

  • Digest and centrifuge the cells to obtain a cell pellet.
  • Resuspend the cells in cryopreservation solution and transfer them to cryovials.
  • Transfer the cryovials into a validated controlled-rate freezing container, following the manufacturer’s instructions for container preparation and cooling conditions.
  • After the initial freezing step, transfer the cryovials to long-term cryogenic storage.

SH-SY5Y Culture Tips and Common Pitfalls

  • Passage Ratio: ATCC recommends a subcultivation ratio of 1:20–1:50 for SH-SY5Y cells under its specified culture conditions. Lower split ratios, such as 1:2–1:3, may be used in laboratory-specific workflows when maintaining higher seeding densities is important, particularly during the expansion of low-density cultures or single-cell-derived clones. The appropriate ratio should be determined based on cell recovery, growth characteristics, and the validated culture conditions.
  • Overgrowth: When cells overgrow, they tend to clump together and gradually detach. Passage the cells before they begin to detach.
  • Cell Clumps: During passaging, some cell clumps may need to be dispersed. Apply moderate force when pipetting.
  • Culture Medium: The higher the cell density, the faster the medium is consumed. Ensure timely medium changes or passaging to maintain healthy growth.

How to Edit the SH-SY5Y Cell Line (KO / KI / Point Mutation)

Gene Modification Projects

Common genetic modifications in the SH-SY5Y cell line include knockout (KO), point mutation (PM), knock-in (KI), overexpression (OE), and interference. Cyagen has optimized preparation and single-cell cloning conditions to deliver monoclonal gene-edited SH-SY5Y cell line models, significantly enhancing the accuracy and reliability of experiments and providing a solid foundation for neuroscience research.

Gene Knockout

Cyagen uses optimized delivery strategies for custom SH-SY5Y gene knockout projects. This approach enables transient delivery of the editing machinery and supports the generation of edited cell populations for subsequent clonal isolation and validation. Editing efficiency and off-target effects depend on the target locus, editing design, and experimental conditions.

Point Mutation

For point mutation and knock-in projects, Cyagen applies donor-assisted editing strategies to introduce defined sequence changes into SH-SY5Y cells. Editing outcomes are influenced by target locus characteristics, donor design, and cellular repair activity. Candidate clones are subsequently screened and validated to identify those carrying the intended modifications.

Stable Cell Line

Cyagen has optimized and upgraded its transfection vector system and, drawing on years of cell biology expertise, has established a mature, stable gene overexpression system. We provide SH-SY5Y stable cell pools or single-cell-derived lines for either stable overexpression of a gene of interest or stable RNA interference (RNAi) to reduce target gene expression.

Gene Editing Tips and Precautions

  • Cell Preparation: Ensure cells are in good condition before transfection, at around 70% density, without too many cell clumps under the microscope.
  • Cell Dissociation: During digestion, disperse the cells into single cells as much as possible.
  • Single Clone Preparation: Use the limiting dilution method to prepare single clones. Use Cyagen's custom culture medium, with an extra 10% serum and appropriate cytokines added. Once clones are observed, replenish with fresh medium and continue cultivation.
  • Clone Expansion: Since SH-SY5Y cells proliferate slowly at low confluency, expand single clones gradually—from a 96-well plate to a 24-well plate, then to 12-well and 6-well plates—rather than transferring directly into a large dish.
  • Clone Validation: Confirm the intended genetic modification using appropriate molecular assays, such as targeted sequencing and copy-number analysis where relevant. For knockout or overexpression models, assess the corresponding RNA or protein expression and, when applicable, functional changes. Verify clonal identity and assess potential unintended modifications according to the project requirements.

Custom Cell Line Gene Editing Services by Cyagen

Cyagen offers a one-stop in vitro service platform for cell line/iPSC gene editing, featuring advanced cell reprogramming, genetic engineering, and cellular differentiation technologies. Combined with our one-stop phenotypic analysis platform, we provide in vitro model development and testing services for cell lines across a range of disease applications. Our optimized gene-editing technology enables rapid editing, including large-fragment excision, large-fragment knock-in, and point mutations with stable expression across various cell lines.

Contact our experts to take advantage of our optimized gene-edited cell line modeling platform for low-cost cell line generation with rapid turnaround and stable expression.

Reference

[1] American Type Culture Collection. SH-SY5Y (ATCC CRL-2266) [Internet]. Manassas (VA): American Type Culture Collection.

[2] de Dios C, Abadin X, Roca-Agujetas V, Jimenez-Martinez M, Morales A, Trullas R, Mari M, Colell A. Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis. Transl Neurodegener. 2023 Mar 9;12(1):10. doi: 10.1186/s40035-023-00343-3. PMID: 36895045; PMCID: PMC9996936.

Subscribe to Receive Updates & Promotions From Cyagen
Subscribe
* Your privacy matters to us. We never share it with third parties.
Explore More
The Brain-Body Axis at SfN 2026: GLP-1, Addiction, and Alzheimer's Research
What Is a Fully Human Antibody Mouse Model, and How Does It Work?
PepGen's DM1 Data: Splicing Correction and the Preclinical Questions Ahead
AMT-130 and HTT-Lowering Therapies: Lessons from Preclinical Huntington's Disease Models
Share
Top
Ready to Elevate Your Research?
Discover how Cyagen can support your research. Let’s start a conversation.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCompany OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2026 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research